Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Tear deficiency medications (OR: 10.54, 95% CI: 3.78 to 29.39), bisphosphonates (OR: 6.83, 95% CI: 3.45 to 13.52), vitamin D with calcium (OR: 6.11, 95% CI: 3.70 to 10.09), non-opioid analgesics (OR: 2.54, 95% CI: 1.85 to 3.50), topical non-steroidal anti-inflammatory drugs (NSAIDs) (OR: 2.02, 95% CI: 1.05 to 3.88), selective serotonin reuptake inhibitors (SSRIs) (OR: 2.86, 95% CI: 1.38 to 5.94), thiazides and related diuretics (OR: 2.54, 95% CI: 1.29 to 4.98), tricyclic and related antidepressants (OR: 2.34, 95% CI: 1.01 to 5.44) and emollients (OR: 1.78, 95% CI: 1.12 to 2.82) showed a significant difference in favour of women.

Source: Gender differences in medication prescription. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study

Study design awaiting verification · PLoS ONE · 2021

Original publication title

Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study

Laurie E. Davies; Andrew Kingston; Adam Todd; Barbara Hanratty

© 2021 Davies et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Considering their complex medical conditions, prescribing is relatively conservative amongst 85-year-olds living in North East England. Prescribing shows significant gender and selected socioeconomic differences. More support for managing preventative medicines, of uncertain benefit, might be helpful in this population.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Polypharmacy is potentially harmful and under-researched amongst the fastest growing subpopulation, the very old (aged ≥85). We aimed to characterise polypharmacy using data from the Newcastle 85+ Study: a prospective cohort of people born in 1921 who turned 85 in 2006 (n = 845).

Source: Background

Abstract: What methods does the paper describe?

The prevalence of polypharmacy at baseline (mean age 85.5) was examined using cut-points of 0, 1, 2 to 4, 5 to 9 and ≥10 medicines: so-called ‘no polypharmacy’, ‘monotherapy’, ‘minor polypharmacy’, ‘polypharmacy’ and ‘hyperpolypharmacy.’ Cross-tabulations and upset plots identified the most frequently prescribed medicines and medication combinations within these categories. Mixed-effects models assessed whether gender and socioeconomic position were associated with prescribing changes over time (mean age 85.5 to 90.5). Participant characteristics were examined through descriptive statistics.

Source: Methods

Abstract: Results

Complex multimorbidity (44.4%, 344/775) was widespread but hyperpolypharmacy was not (16.0%, 135/845). The median medication count was six (interquartile range 4 to 8). Preventative medicines were common to all polypharmacy categories, and prescribing regimens were diverse. Nitrates and oral anticoagulants were more frequently prescribed for men, whereas bisphosphonates, non-opioid analgesics and antidepressants were more common in women. Cardiovascular medicines, including loop diuretics, tended to be more frequently prescribed for socioeconomically disadvantaged people (<25th centile Index of Multiple Deprivation (IMD)), despite no difference in the prevalence of cardiovascular disease (p = 0.56) and diabetes (p = 0.92) by IMD.

Source: Results

Abstract: Conclusion

Considering their complex medical conditions, prescribing is relatively conservative amongst 85-year-olds living in North East England. Prescribing shows significant gender and selected socioeconomic differences. More support for managing preventative medicines, of uncertain benefit, might be helpful in this population.

Source: Conclusion
Authors’ abstract

Background

Polypharmacy is potentially harmful and under-researched amongst the fastest growing subpopulation, the very old (aged ≥85). We aimed to characterise polypharmacy using data from the Newcastle 85+ Study: a prospective cohort of people born in 1921 who turned 85 in 2006 (n = 845).

Methods

The prevalence of polypharmacy at baseline (mean age 85.5) was examined using cut-points of 0, 1, 2 to 4, 5 to 9 and ≥10 medicines: so-called ‘no polypharmacy’, ‘monotherapy’, ‘minor polypharmacy’, ‘polypharmacy’ and ‘hyperpolypharmacy.’ Cross-tabulations and upset plots identified the most frequently prescribed medicines and medication combinations within these categories. Mixed-effects models assessed whether gender and socioeconomic position were associated with prescribing changes over time (mean age 85.5 to 90.5). Participant characteristics were examined through descriptive statistics.

Results

Complex multimorbidity (44.4%, 344/775) was widespread but hyperpolypharmacy was not (16.0%, 135/845). The median medication count was six (interquartile range 4 to 8). Preventative medicines were common to all polypharmacy categories, and prescribing regimens were diverse. Nitrates and oral anticoagulants were more frequently prescribed for men, whereas bisphosphonates, non-opioid analgesics and antidepressants were more common in women. Cardiovascular medicines, including loop diuretics, tended to be more frequently prescribed for socioeconomically disadvantaged people (<25th centile Index of Multiple Deprivation (IMD)), despite no difference in the prevalence of cardiovascular disease (p = 0.56) and diabetes (p = 0.92) by IMD.

Conclusion

Considering their complex medical conditions, prescribing is relatively conservative amongst 85-year-olds living in North East England. Prescribing shows significant gender and selected socioeconomic differences. More support for managing preventative medicines, of uncertain benefit, might be helpful in this population.

Publication and source details

Original title: Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study

Laurie E. Davies; Andrew Kingston; Adam Todd; Barbara Hanratty

PLoS ONE · 2021

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: L.E.Davies2@newcastle.ac.uk
© 2021 Davies et al2021Davies et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.This paper presents independent research funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR) [SPCR-2014-10043]. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The Newcastle 85+ Study has been funded by the Medical Research Council, Biotechnology and Biological Sciences Research Council, the Dunhill Medical Trust and the National Institute for Health Research School for Primary Care Research. Parts of the work have also been funded by the British Heart Foundation, Unilever Corporate Research, Newcastle University, NHS North of Tyne (Newcastle Primary Care Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T13:35:09.096091+00:00

DOI: 10.1371/journal.pone.0245648 · PMC7815158